Article info

Extended report
Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension

Authors

  1. Correspondence to Dr Edward Keystone, The Rebecca MacDonald Centre for Arthritis & Autoimmune Diseases, Mount Sinai Hospital, 60 Murray St., Room 2-006, Box 4, Toronto, ON, Canada M5T 3L9; edkeystone{at}mtsinai.on.ca
View Full Text

Citation

Keystone E, Landewé R, van Vollenhoven R, et al
Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension

Publication history

  • Received March 27, 2013
  • Revised July 5, 2013
  • Accepted July 15, 2013
  • First published August 5, 2013.
Online issue publication 
October 30, 2014

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.